
Sign up to save your podcasts
Or


Transforming CLL care: measurable residual disease (MRD) guided stopping, smart triplet selection, and next‑gen Bruton tyrosine kinase (BTKs)—practical insights. Credit available for this activity expires: 02/19/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/chronic-lymphocytic-leukemia-cll-review-combination-2026a10004ku?ecd=bdc_podcast_libsyn_mscpedu
By Medscape4.3
2525 ratings
Transforming CLL care: measurable residual disease (MRD) guided stopping, smart triplet selection, and next‑gen Bruton tyrosine kinase (BTKs)—practical insights. Credit available for this activity expires: 02/19/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/chronic-lymphocytic-leukemia-cll-review-combination-2026a10004ku?ecd=bdc_podcast_libsyn_mscpedu

135 Listeners

708 Listeners

507 Listeners

167 Listeners

103 Listeners

901 Listeners

14 Listeners

16 Listeners

298 Listeners

267 Listeners

3,379 Listeners

1,141 Listeners

194 Listeners

90 Listeners

520 Listeners

367 Listeners

173 Listeners

60 Listeners

7 Listeners

440 Listeners